Class II — Potential Health Hazard

Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

UFSK Treatment chair 500 XLE- Treatment chair for positioning and Recalled by UFSK - International OSYS Gmbh Due to Service life of the electrical seat part drive...

Date: May 31, 2023
Company: UFSK - International OSYS Gmbh
Status: Ongoing
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact UFSK - International OSYS Gmbh directly.

Affected Products

UFSK Treatment chair 500 XLE- Treatment chair for positioning and support of the patient during diagnostic and therapeutic treatments of temporary to short-term duration, especially in ophthalmology Art.no. / REF no.: 15000004 Art.no. / REF no.: 15000006

Quantity: 239 chairs US

Why Was This Recalled?

Service life of the electrical seat part drive of the treatment chair may be shortened unexpectedly after several years of use due to a potential wear-related reduction in the self-locking of the drive and may remain undetected. A worsened self-locking of the seat drive can lead to overriding the drive s end position when positioning the patient with the seat part in an inclined position

Where Was This Sold?

This product was distributed nationwide across all 50 states.

Affected (51 states)Not affected

About UFSK - International OSYS Gmbh

UFSK - International OSYS Gmbh has 1 total recall tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report